Joplin Globe2d
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist ...
Yahoo Finance10d
Olfactive Biosolutions Begins Production of Patented GLP-1/GIP Weight Loss and Blood Sugar Reduction Supplement
These ectopic receptors influence GLP-1 and GIP secretion, serotonin and dopamine secretion, blood pressure, muscle ...
News Medical on MSN5d
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or death
A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
Hosted on MSN3mon
Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease
New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor ... loss of kidney function by almost 60% when added to GLP-1RAs.
Business Wire1mon
Olfactive Biosolutions Granted Second GLP-1 Patent to Repurpose Food Molecules for Weight Loss and Blood Sugar Reduction
These ectopic receptors influence GLP-1 and GIP secretion, serotonin and dopamine secretion, blood pressure, muscle regeneration, bone remodeling, bronchodilation, kidney function and many other ...